Check the sources.
Article citations support individual statements. This library collects the linked references so you can read their original context.
- Drug checking | New Zealand Ministry of Health
- Drug testing and checking | Crew
- Drug Checking Kits & Services | DanceSafe
- Drug Checking Service Provider Licensing Handbook | New Zealand Ministry of Health
- Drug checking | Victorian Department of Health
- Three-day blues after ecstasy/MDMA use | Drug and Alcohol Dependence
- MDMA (ecstasy) | healthdirect Australia
- MDMA | Health Canada
- MDMA (ecstasy): What health practitioners need to know | Disease-a-Month
- Monday mood decline after weekend ecstasy use | Drug and Alcohol Dependence Reports
- DanceSafe: Fentanyl Test Strip Instructions
- DanceSafe: We Updated Our Fentanyl Test Strip Instructions (October 2025)
- CDC: Fentanyl Test Strips
- Krotulski et al. (2024), Testing the test strips
- Peiper et al. (2019), An assessment of drug checking devices
- Scoping review: Fentanyl Test Strips for Harm Reduction
- California Department of Public Health: Fentanyl Test Strip FAQs
- NIDA: MDMA (Ecstasy/Molly) DrugFacts
- Long-term neurocognitive effects after sustained abstinence | Journal of Psychopharmacology
- DanceSafe: Reagent Kit Instructions
- DanceSafe: Reagent Instructions, Version 17 (Spring 2024)
- MDMA (ecstasy) | Health Service Executive Ireland
- Serotonin syndrome | NHS
- Serotonin syndrome | MedlinePlus
- Health harms of drugs: MDMA and related substances | UK Department of Health
- DanceSafe: Important Reagent Reaction Updates
- UNODC: Recommended methods for the identification and analysis of amphetamine, methamphetamine and their ring-substituted analogues in seized materials
- Hyponatremia | Merck Manual Consumer Version
- Increasing detections of PMMA in tablets sold as ecstasy | UNODC
- Novel stimulants sold as MDMA, cocaine or speed | Victorian Department of Health
- Alert on synthetic cathinones sold as Molly | Colombian Early Warning System
- Drug Scheduling | U.S. Drug Enforcement Administration
- Complete Response Letter, NDA 215455 | U.S. Food and Drug Administration
- Drugs penalties | GOV.UK
- Misuse of Drugs Regulations 2001, Schedule 1 | legislation.gov.uk
- ACMD evidence standard operating procedure | GOV.UK
- BtMG, Anlage I | Gesetze im Internet
- Betäubungsmittelgesetz | Gesetze im Internet
- Difference between hard and soft drugs | Government.nl
- MDMA: Beyond Ecstasy | Government of the Netherlands
- Consolidated LVFS 2011:10 narcotics lists | Swedish Medical Products Agency
- Narcotics and narcotics precursors | Swedish Medical Products Agency
- Poisons Standard—October 2026 | Federal Register of Legislation
- Access MDMA or psilocybine (consumers) | TGA
- Special Access Program requests involving psychedelic-assisted psychotherapy | Health Canada
- Resolution 315 of 2020 | INVIMA Legal Compilation
- Decree 2114 of 2023 | Función Pública
- Law 30 of 1986 | Función Pública
- Constitutional Court decision C-491/2012
Sources checked November 14, 2026. Availability and guidance can change. Listing is not endorsement by the named organisation.